Juvéderm Volbella lips in the perioral area: a 12-month prospective, multicenter, open-label study
Hyaluronic acid dermal fillers are frequently used for lip augmentation, and a new filler has been developed with characteristics especially suited for the lips.
Four European sites treated 60 subjects with Volbella Allergan injectable gel in the perioral area, and subjects returned to the clinic at 1, 3, 6, 9, and 12 months for follow-up.
The primary effectiveness endpoint established a priori was a Month 3 responder rate on the 4-point Lip Fullness Scale (LFS) of ≥40% and statistically > 0%, where responders improved ≥ 1 point from baseline on the investigator’s assessment of LFS. At follow-up, subjects assessed lip fullness goal achievement, the look and feel of their lips, and their satisfaction with the effects of treatment.
Hier vindt u het gehele artikel over Volbella
Vanaf februari 2013 gaat Allergan van start met Volbella workshops in Nederland en België.